Johnson & Johnson Single Dose Vaccine Given Green Light

This week brings encouraging news: Johnson & Johnson’s one-dose COVID-19 vaccine has become the third COVID-19 vaccine given Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).  

What’s more, the Johnson & Johnson vaccine requires only one dose, which will help speed-up the vaccination process.  

Here are Four Things to Know About the Johnson & Johnson COVID-19 Vaccine:  

  1. The U.S. Food and Drug Administration (FDA) has now approved three COVID-19 vaccines for Emergency Use Authorization (EUA). It is the first single-dose vaccine approved for EUA.  
  2. Johnson & Johnson’s single-dose vaccine uses a harmless adenovirus to activate an immune response to the coronavirus spike protein. It shows mild side effects like other vaccines.  
  3. Clinical trials showed it is 72 percent effective against COVID-19 infection and 86 percent effective against severe illness and death in those who received the vaccine. No COVID-19 deaths were reported in those vaccinated during clinical trials.  
  4. It doesn’t matter which vaccine you receive. The most important thing is to get vaccinated when it is your turn. Vaccination is the most effective way to end the COVID-19 pandemic and protect yourself and those you come in contact with.  

It’s still important, however, to continue wearing a mask, washing your hands often, avoiding crowds and staying at least 6 feet away from others.  

Together we can end the pandemic! 

Leave a Reply